JERUSALEM (Reuters) - The U.S. ambassador to Israel visited its bio-chemical defence laboratory and was briefed on a coronavirus vaccine prototype for which it is seeking U.S. Food and Drug Administration (FDA) regulation, a U.S. official said on Wednesday.
Sentynl acquires, develops and commercialises prescription products, according to the company's website. It holds rights for opioid-based drug Abstral used for pain management among cancer patients.
Cadila Healthcare to acquire Claris Lifesciences for Rs 3,400 crore